Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Mastrolorenzo

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Skinmed|March 18, 2024
An Unusual Clinical Presentation of Mibelli's PorokeratosisAntonio Mastrolorenzo, Daniela Massi, Nicola Pimpinelli
Journal of Enzyme Inhibition and Medicinal Chemistry|November 8, 2002
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agentsAndrea Scozzafava, Antonio Mastrolorenzo, Claudiu T Supuran
Current Drug Targets. Infectious Disorders|December 8, 2004
New advances in HIV entry inhibitors developmentStefano Rusconi, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Current Pharmaceutical Design|October 5, 2006
Phosphodiesterase 5 inhibitors--drug design and differentiation based on selectivity, pharmacokinetic and efficacy profilesClaudiu T Supuran, Antonio Mastrolorenzo, Giuseppe Barbaro, et al.
Mini Reviews in Medicinal Chemistry|February 18, 2004
Antiviral sulfonamide derivativesClaudiu T Supuran, Alessio Innocenti, Antonio Mastrolorenzo, et al.
Current Pharmaceutical Design|May 17, 2005
Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcomeGiuseppe Barbaro, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Current Cancer Drug Targets|August 22, 2002
Sulfonamides and sulfonylated derivatives as anticancer agentsAngela Casini, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Current Topics in Medicinal Chemistry|July 14, 2007
An update in the development of HIV entry inhibitorsStefano Rusconi, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Mini Reviews in Medicinal Chemistry|July 29, 2004
COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agentsClaudiu T Supuran, Angela Casini, Antonio Mastrolorenzo, et al.
Acta Dermato-Venereologica|November 12, 2003
A curious keloid of the penisAntonio Mastrolorenzo, Anna Lisa Rapaccini, Luana Tiradritti, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Skinmed|March 18, 2024
An Unusual Clinical Presentation of Mibelli's PorokeratosisAntonio Mastrolorenzo, Daniela Massi, Nicola Pimpinelli
Journal of Enzyme Inhibition and Medicinal Chemistry|November 8, 2002
Non-peptidic chemokine receptors antagonists as emerging anti-HIV agentsAndrea Scozzafava, Antonio Mastrolorenzo, Claudiu T Supuran
Current Drug Targets. Infectious Disorders|December 8, 2004
New advances in HIV entry inhibitors developmentStefano Rusconi, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Current Pharmaceutical Design|October 5, 2006
Phosphodiesterase 5 inhibitors--drug design and differentiation based on selectivity, pharmacokinetic and efficacy profilesClaudiu T Supuran, Antonio Mastrolorenzo, Giuseppe Barbaro, et al.
Mini Reviews in Medicinal Chemistry|February 18, 2004
Antiviral sulfonamide derivativesClaudiu T Supuran, Alessio Innocenti, Antonio Mastrolorenzo, et al.
Current Pharmaceutical Design|May 17, 2005
Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcomeGiuseppe Barbaro, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Current Cancer Drug Targets|August 22, 2002
Sulfonamides and sulfonylated derivatives as anticancer agentsAngela Casini, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Current Topics in Medicinal Chemistry|July 14, 2007
An update in the development of HIV entry inhibitorsStefano Rusconi, Andrea Scozzafava, Antonio Mastrolorenzo, et al.
Mini Reviews in Medicinal Chemistry|July 29, 2004
COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agentsClaudiu T Supuran, Angela Casini, Antonio Mastrolorenzo, et al.
Acta Dermato-Venereologica|November 12, 2003
A curious keloid of the penisAntonio Mastrolorenzo, Anna Lisa Rapaccini, Luana Tiradritti, et al.
Pageof 3